Literature DB >> 8995661

Hyper-antigenic variation occurs with human rhinovirus type 17.

L J Patterson1, V V Hamparian.   

Abstract

Of 90 human rhinovirus (RV) serotypes tested, 50 can be placed into 16 groups according to antigenic relationships. It has been suggested that antigenic variants might arise in nature by immunologic pressure. To investigate this possibility, attempts were made to select variants by cloning 16 different plaque-purified RV serotypes in the presence of homologous, polyclonal antisera. Isolates were examined for evidence of variation in serum cross-neutralization tests using parental antisera and, in some cases, antisera prepared for the isolates. Only RV type 17 (RV-17) yielded major antigenic variants after cloning. With some variants, as much as a 500-fold difference in neutralizing titer was obtained with the parental antiserum. By using antisera for two of the variants, it was determined that they are prime strains of the parental RV-17. Continuing attempts at immunoselection by using antisera for one of these prime strains yielded additional antigenic variants. By using antisera prepared for three of these new variants, it was determined that one of them is a prime strain of the virus from which it was derived. Cross-neutralization tests with the two remaining isolates indicate that, according to conventional practice, they no longer would be classified as RV-17.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995661      PMCID: PMC191192     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Studies of natural population variability of parainfluenza viruses during their epidemic circulation.

Authors:  T I Yurlova; M V Sverkunova; V A Furaeva; V P Sukhinin; G S Shitikova; D Fedová; L Kunzová
Journal:  Acta Virol       Date:  1991-01       Impact factor: 1.162

Review 2.  The fastest genome evolution ever described: HIV variation in situ.

Authors:  S Wain-Hobson
Journal:  Curr Opin Genet Dev       Date:  1993-12       Impact factor: 5.578

3.  Immunodominance and antigenic variation of the principal neutralization domain of HIV-1.

Authors:  G Zwart; H Langedijk; L van der Hoek; J J de Jong; T F Wolfs; C Ramautarsing; M Bakker; A de Ronde; J Goudsmit
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

4.  Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child.

Authors:  E Rocha; N J Cox; R A Black; M W Harmon; C J Harrison; A P Kendal
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

5.  Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection.

Authors:  B Borrego; I S Novella; E Giralt; D Andreu; E Domingo
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual.

Authors:  R M Howell; J E Fitzgibbon; M Noe; Z J Ren; D J Gocke; T A Schwartzer; D T Dubin
Journal:  AIDS Res Hum Retroviruses       Date:  1991-11       Impact factor: 2.205

7.  Modification of foot-and-mouth disease virus O1 Caseros after serial passages in the presence of antiviral polyclonal sera.

Authors:  E R Rojas; E Carrillo; M Schiappacassi; R Campos
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

8.  Antigenic variants of influenza A virus (PR8 strain). V. Virulence, antigenic potency, and cross-protection tests in mice of the original and second series.

Authors:  C G LOOSLI; D HAMRE; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

9.  Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine.

Authors:  D HAMRE; C G LOOSLI; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

10.  Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine.

Authors:  D HAMRE; C G LOOSLI; P GERBER
Journal:  J Exp Med       Date:  1958-06-01       Impact factor: 14.307

View more
  1 in total

1.  Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus.

Authors:  Steven M Szczepanek; Roger W Barrette; Debra Rood; Diana Alejo; Lawrence K Silbart
Journal:  Clin Vaccine Immunol       Date:  2012-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.